JNBA Financial Advisors Sells 216 Shares of CVS Health Co. (NYSE:CVS)

JNBA Financial Advisors lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 3.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,438 shares of the pharmacy operator’s stock after selling 216 shares during the quarter. JNBA Financial Advisors’ holdings in CVS Health were worth $244,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. MidAtlantic Capital Management Inc. bought a new stake in CVS Health during the 3rd quarter worth $25,000. Ridgewood Investments LLC grew its holdings in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares during the last quarter. Stonebridge Financial Group LLC acquired a new position in shares of CVS Health in the fourth quarter valued at approximately $28,000. Livelsberger Financial Advisory bought a new position in CVS Health in the 3rd quarter valued at approximately $31,000. Finally, Legacy Investment Solutions LLC bought a new stake in CVS Health during the 3rd quarter worth approximately $31,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

Shares of CVS Health stock opened at $65.71 on Friday. The business has a 50-day simple moving average of $51.11 and a 200 day simple moving average of $56.08. The firm has a market capitalization of $82.68 billion, a price-to-earnings ratio of 16.68, a PEG ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. On average, research analysts anticipate that CVS Health Co. will post 5.14 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.05%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

Analysts Set New Price Targets

Several research firms have recently issued reports on CVS. Mizuho dropped their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Cantor Fitzgerald raised CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday. Royal Bank of Canada decreased their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Truist Financial upped their target price on CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a report on Thursday. Finally, Leerink Partners upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $55.00 to $75.00 in a report on Thursday. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $70.28.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.